<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Anti-CRISPR Proteins Project - AI Gene Review Projects</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-primary: #3498db;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1200px;
            margin: 0 auto;
        }

        .breadcrumb {
            margin-bottom: 1.5rem;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .breadcrumb a {
            color: var(--color-primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        h2 {
            font-size: 1.75rem;
            font-weight: 600;
            margin-top: 2rem;
            margin-bottom: 1rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        h3 {
            font-size: 1.25rem;
            font-weight: 600;
            margin-top: 1.5rem;
            margin-bottom: 0.75rem;
            color: #374151;
        }

        h4 {
            font-size: 1rem;
            font-weight: 600;
            margin-top: 1.25rem;
            margin-bottom: 0.5rem;
            color: #4b5563;
        }

        p {
            margin-bottom: 1rem;
        }

        a {
            color: var(--color-primary);
            text-decoration: none;
        }

        a:hover {
            text-decoration: underline;
        }

        /* Gene symbol links */
        .content a[href*="/genes/"] {
            background-color: #dbeafe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-weight: 500;
        }

        .content a[href*="/genes/"]:hover {
            background-color: #bfdbfe;
        }

        ul, ol {
            margin-bottom: 1rem;
            padding-left: 2rem;
        }

        li {
            margin-bottom: 0.25rem;
        }

        code {
            background: #f4f4f4;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-family: 'SFMono-Regular', Consolas, 'Liberation Mono', Menlo, monospace;
            font-size: 0.875em;
        }

        pre {
            background: #1f2937;
            color: #f9fafb;
            padding: 1rem;
            border-radius: 0.5rem;
            overflow-x: auto;
            margin-bottom: 1rem;
        }

        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }

        blockquote {
            border-left: 4px solid var(--color-primary);
            margin-left: 0;
            padding-left: 1.5rem;
            color: #4b5563;
            font-style: italic;
            margin-bottom: 1rem;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
        }

        th, td {
            border: 1px solid var(--border-color);
            padding: 0.75rem;
            text-align: left;
        }

        th {
            background-color: var(--bg-light);
            font-weight: 600;
            color: var(--text-muted);
            text-transform: uppercase;
            font-size: 0.75rem;
            letter-spacing: 0.05em;
        }

        tr:nth-child(even) {
            background-color: #f9fafb;
        }

        tr:hover {
            background-color: #f3f4f6;
        }

        /* Mermaid diagrams */
        .mermaid {
            text-align: center;
            margin: 2rem 0;
            background: white;
            padding: 1.5rem;
            border-radius: 0.5rem;
            border: 1px solid var(--border-color);
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        /* Warnings section */
        .warnings {
            background-color: #fef3c7;
            border: 1px solid #fde68a;
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 2rem;
        }

        .warnings h3 {
            color: #92400e;
            margin-top: 0;
            margin-bottom: 0.5rem;
            font-size: 1rem;
        }

        .warnings ul {
            margin-bottom: 0;
            color: #78350f;
        }

        /* Task lists (checkboxes) */
        li input[type="checkbox"] {
            margin-right: 0.5rem;
        }

        /* Status badges */
        .badge {
            display: inline-block;
            padding: 0.25rem 0.625rem;
            border-radius: 9999px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
        }

        .badge-success {
            background-color: #d1fae5;
            color: #065f46;
        }

        .badge-warning {
            background-color: #fef3c7;
            color: #92400e;
        }

        .badge-info {
            background-color: #dbeafe;
            color: #1e40af;
        }

        /* Content wrapper */
        .content {
            margin-bottom: 2rem;
        }

        /* Footer */
        footer {
            margin-top: 3rem;
            padding-top: 1.5rem;
            border-top: 1px solid var(--border-color);
            color: var(--text-muted);
            font-size: 0.875rem;
            text-align: center;
        }

        footer small {
            display: block;
        }
    </style>
    <!-- Mermaid.js for diagram rendering -->
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <nav class="breadcrumb">
        <a href="../index.html">Home</a> &raquo;
        <a href="index.html">Projects</a> &raquo;
        Anti-CRISPR Proteins Project
    </nav>

    <header class="header">
        <h1>Anti-CRISPR Proteins Project</h1>
        
    </header>

    

    <div class="content">
        <h1 id="anti-crispr-proteins-project">Anti-CRISPR Proteins Project</h1>
<h2 id="overview">Overview</h2>
<p>This project tracks the annotation review of anti-CRISPR (Acr) proteins - phage-encoded inhibitors of bacterial CRISPR-Cas immune systems. These proteins represent a fascinating example of evolutionary arms race between bacteria and their viral predators, and present unique challenges for GO annotation:</p>
<ol>
<li><strong>Novel molecular mechanisms</strong> - Acr proteins often have unique mechanisms not well-captured by existing GO terms</li>
<li><strong>Dual-targeting strategies</strong> - Some Acrs interact with both protein and RNA components</li>
<li><strong>Regulatory complexity</strong> - Expression is tightly regulated via Aca (anti-CRISPR associated) repressors</li>
<li><strong>Sparse annotations</strong> - Many Acr proteins have only generic IEA annotations</li>
</ol>
<p>These proteins are excellent targets for AI-assisted curation because their mechanisms are well-studied structurally but annotations lag behind.</p>
<p><strong>Source</strong>: Presented at Gene Ontology Consortium Meeting, October 2025, Cambridge UK. See <a href="https://github.com/ai4curation/ai-gene-review">ai4curation/ai-gene-review</a>.</p>
<h2 id="key-concepts">Key Concepts</h2>
<h3 id="anti-crispr-mechanisms">Anti-CRISPR Mechanisms</h3>
<ul>
<li><strong>Type I-F inhibitors</strong> (AcrIF family) - Target Csy surveillance complex</li>
<li><strong>Type I-<a href="../../genes/BPT4/E/E-ai-review.html">E</a> inhibitors</strong> (AcrIE family) - Target Cascade complex</li>
<li><strong>Type II inhibitors</strong> (AcrIIA/IIC) - Target Cas9/Cas12</li>
<li><strong>Type III inhibitors</strong> - Target Csm/Cmr complexes</li>
</ul>
<h3 id="inhibition-strategies">Inhibition Strategies</h3>
<ul>
<li>Blocking DNA recognition</li>
<li>Preventing R-loop formation</li>
<li>Mimicking DNA substrates</li>
<li>Direct crRNA binding (unique mechanism)</li>
<li>Enzymatic inactivation</li>
</ul>
<h2 id="featured-examples">Featured Examples</h2>
<h3 id="acrf8-pectobacterium-phage-zf40"><a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a> (Pectobacterium phage ZF40)</h3>
<p><strong>Organism</strong>: BPZF4 (bacteriophage)<br />
<strong>UniProt</strong>: H9C181<br />
<strong>Status</strong>: COMPLETE</p>
<p><strong>Key Findings</strong>:<br />
- 92-amino acid protein that inhibits Type I-F CRISPR-Cas system<br />
- Unique dual-targeting mechanism: binds BOTH Cas7f protein backbone AND crRNA scaffold<br />
- Contacts nucleotides U[+21], U[+22], G[+23] of crRNA at &lt;4Å distance<br />
- Blocks R-loop formation and prevents target DNA recognition<br />
- Cryo-EM structure at 3.42Å resolution (PMID:32170016)</p>
<p><strong>Annotation Issues Identified</strong>:<br />
- <code>GO:0052170</code> (symbiont-mediated suppression of host innate immune response) - Too general<br />
  - <strong>Action</strong>: MODIFY → <code>GO:0098672</code> (symbiont-mediated suppression of host CRISPR-cas system)<br />
- Missing core function annotation for ribonucleoprotein complex binding</p>
<p><strong>Proposed New GO Term</strong>:<br />
- <strong>Name</strong>: CRISPR RNA binding anti-CRISPR activity<br />
- <strong>Justification</strong>: Current terms don't distinguish between Acrs that only bind Cas proteins vs. those that directly contact crRNA. <a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a> represents a unique class with dual protein-RNA binding.</p>
<h2 id="genes-for-review">Genes for Review</h2>
<h3 id="priority-1-structurally-characterized-acrs">Priority 1: Structurally Characterized Acrs</h3>
<table>
<thead>
<tr>
<th>Species</th>
<th>Gene</th>
<th>CRISPR Type</th>
<th>Status</th>
</tr>
</thead>
<tbody>
<tr>
<td>BPZF4</td>
<td><a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a></td>
<td>Type I-F</td>
<td>COMPLETE</td>
</tr>
</tbody>
</table>
<h3 id="priority-2-other-acr-families">Priority 2: Other Acr Families</h3>
<p>(To be identified - AcrIF, AcrIE, AcrIIA families)</p>
<h3 id="priority-3-aca-regulators">Priority 3: Aca Regulators</h3>
<p>(Anti-CRISPR associated proteins that regulate Acr expression)</p>
<h2 id="key-mechanisms-to-annotate">Key Mechanisms to Annotate</h2>
<ol>
<li><strong>Surveillance complex binding</strong> - <code>GO:0043021</code> ribonucleoprotein complex binding</li>
<li><strong>CRISPR-Cas suppression</strong> - <code>GO:0098672</code> symbiont-mediated suppression of host CRISPR-cas system</li>
<li><strong>DNA mimic function</strong> - Where Acrs structurally mimic DNA</li>
<li><strong>crRNA binding</strong> - Direct RNA contacts (needs new term?)</li>
</ol>
<h2 id="key-references">Key References</h2>
<ul>
<li>Bondy-Denomy J et al. (2013) Nature - Anti-CRISPR discovery</li>
<li>Pawluk A et al. (2016) Cell - AcrIF mechanisms</li>
<li>Wang J et al. (2020) Nat Commun - <a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a>/F9/F6 cryo-EM structures (PMID:32170016)</li>
<li>Stanley SY et al. (2019) Cell - Aca repressor mechanisms (PMID:31474367)</li>
</ul>
<h2 id="related-projects">Related Projects</h2>
<ul>
<li>Phage-host interactions</li>
<li>Bacterial immune systems</li>
</ul>
<hr />
<h1 id="status">STATUS</h1>
<h2 id="completed-reviews">Completed Reviews</h2>
<ul>
<li>[x] BPZF4/<a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a> - Type I-F inhibitor with dual protein-RNA binding</li>
</ul>
<h2 id="pending">Pending</h2>
<ul>
<li>[ ] Identify additional Acr proteins in UniProt/QuickGO</li>
<li>[ ] Review Aca regulator annotations</li>
<li>[ ] Propose new GO terms for crRNA-binding mechanisms</li>
</ul>
<p>Last updated: 2026-01-22</p>
<h1 id="notes">NOTES</h1>
<h2 id="2026-01-22">2026-01-22</h2>
<p><strong>Project Creation</strong></p>
<p>Created project to track anti-CRISPR protein annotations.</p>
<p><strong><a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a> Highlights</strong>:<br />
- Unique dual-targeting: binds both Cas7f protein AND crRNA directly<br />
- Cryo-EM structure shows &lt;4Å contacts with crRNA nucleotides<br />
- Expression regulated by Aca2 repressor in negative feedback loop<br />
- Proposed new GO term for crRNA-binding anti-CRISPR mechanism</p>
<p>The <a href="../../genes/BPZF4/AcrF8/AcrF8-ai-review.html">AcrF8</a> example demonstrates:<br />
1. Need for more specific GO terms for CRISPR-Cas inhibition mechanisms<br />
2. Value of structural biology in informing function annotations<br />
3. Importance of distinguishing protein-only vs. protein+RNA binding mechanisms</p>
    </div>

    <footer>
        <small>Generated from ANTI_CRISPR.md</small>
        <small>AI Gene Review Project</small>
    </footer>
</body>
</html>